Brian A. Jonas

Also affiliated with University of California Davis Medical Center, UC Davis Health, University of California, Davis

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia”.

A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia

Blood Neoplasia(2025)10.1016/j.bneo.2025.100126

N/A

0.330DataRank · unranked

8 citations

Gabriel N. Mannis, Yazan F. Madanat, Brian A. Jonas, Neil Dunavin, Gail J. Roboz +15 more

Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients

Blood Cancer Journal(2021)10.1038/s41408-020-00400-4

N/A

0DataRank · unranked

23 citations

Ann Brunson, Joseph M. Tuscano, Brian A. Jonas, Rasmus T. Hoeg, Ted Wun +2 more

Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia

Cancers(2022)10.3390/cancers14153634

N/A

0DataRank · unranked

7 citations

Brian A. Jonas, Tali Azenkot

A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.006

N/A

0DataRank · unranked

3 citations

JULIAN R. DAVIS, Brian A. Jonas, Joseph M. Tuscano, Aaron S. Rosenberg, Mehrdad Abedi +1 more

Phase I trial of the combination of ibrutinib and lenalidomide of the treatment of patients with MDS who have failed standard therapy or who are unfit for or refuse standard therapy

Leukemia Research(2022)10.1016/j.leukres.2022.106947

N/A

0DataRank · unranked

4 citations

Joseph M. Tuscano, Lihong Qi, Brian A. Jonas, Samantha Fisch

Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax

Blood(2023)10.1182/blood-2023-187861

N/A

0DataRank · unranked

5 citations

Joseph G. Jurcic, Maria R. Baer, William Blum, P. Brent Ferrell, Brian A. Jonas +7 more

Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center

Leukemia Research(2022)10.1016/j.leukres.2022.106885

N/A

0DataRank · unranked

8 citations

Benjamin Moskoff, Gwendolyn Ho, Matthew E. Tenold, Tali Azenkot, Margaret L. Krackeler +12 more